The doses being studied in CD are lower than botox, so if that data comes in strong the specious argument that dose is responsible for the higher response rates and longer duration will further be discredited
AGN can leverage its huge sales force to seed doubt. The reps will just throw the equivalent of FUD to the providers. RVNC will need to partner to have the share of voice necessary to counter that crap. RVNC doesn't have a choice unfortunately.
Market Data 
Markets 
AI
